As part of the agreement, Dvir's lab and Bayer will aim to test new cardiology medication for toxicity and efficacy.

A 15-member delegation from the German pharma giant is currently on a two-day trip to meet with some 32 local startups in biotech and digital health.

The three companies will cooperate on the development of best practices for the application of crop protection compounds via drip irrigation.